HongKong Shijingu Technology Co.,Ltd
Products
Contact Us
  • Contact Person : Ms. Reta Reta
  • Company Name : HongKong Shijingu Technology Co.,Ltd
  • Tel : 86-755-84556470
  • Fax : 86-755-84556470
  • Address : KL, HONGKONG,JORDAN,25 WAI CHING
  • Country/Region : Hong Kong

Anastrozole Anti Estrogen Hormones Powder Arimidex Antineoplastic Raw Pharmaceutical Materials

Anastrozole Anti Estrogen Hormones Powder  Arimidex Antineoplastic Raw Pharmaceutical  Materials
Product Detailed
Related Categories:Pharmaceutical
Anastrozole Anti Estrogen Hormones Powder Arimidex Antineoplastic Raw Pharmaceutical Materials Anastrozole Quick Detail: 1, Alias: Anastrozole Arimidex 2, Sales.Rep :eva.pharmade 3, Purity:99%min 4, Character: White crystalline powder. 5, Usage: An aromatase inhibitor. Used as an antineoplastic raw materials. Potent selective triazole aromatase inhibitors, can inhibit the cytochrome P-450 aromatase enzyme which depends blocking the biosynthesis of estrogen, and estrogen to stimulate breast cancer cell growth factors. Treatment of breast cancer, especially for those with hormone relapse after adjuvant therapy after menopause for women with advanced breast cancer. Description: Arimidex (anastrozole) is the aromatase inhibitor of choice. Arimidex’s mechanism of action — blocking conversion of aromatizable steroids to estrogen — is in contrast to the mechanism of action of anti-estrogens such as clomiphene (Clomid) or tamoxifen (Nolvadex), which block estrogen receptors in some tissues, and activate estrogen receptors in others. Applications: Anastrozole Arimidex Antiestrogens steroids powder The drug is appropriately used when using substantial amounts of aromatizing steroids, or when one is prone to gynecomastia and using moderate amounts of such steroids. Arimidex does not have the side effects of aminoglutethimide (Cytadren) and can achieve a high degree of estrogen blockade, much moreso than Cytadren. It is possible to reduce estrogen too much with Arimidex, and for this reason blood tests, or less preferably salivary tests, should be taken after the first week of use to determine if the dosing is correct.


Copyright Notice @ 2008-2022 ECBAY Limited and/or its subsidiaries and licensors. All rights reserved.